Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Baxter Qiaoguang Pharmaceutical is a prominent joint venture between Baxter International and Guangzhou Pharmaceutical Holdings Limited (GPHL). The company specializes in the manufacture and distribution of intravenous (IV) solutions and parenteral nutrition products within the Chinese market. Its portfolio includes a wide range of large-volume parenterals, including amino acid injections and fat emulsions designed for clinical nutrition support. Operating out of Guangzhou, the company leverages Baxter's global expertise in medication delivery and GPHL's extensive local network to provide essential healthcare products to hospitals across China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Baite Jiaoguang Medical Product.